Sarah K Walsh
banner
sarahkwalsh.bsky.social
Sarah K Walsh
@sarahkwalsh.bsky.social
Post Doctoral Research Associate with Ed Hutchinson at the MRC-University of Glasgow Centre for Virus Research currently investigating biosafe methods to study H5N1 (she/her)
Pinned
Excited to be at my first @microbiologysociety.org annual conference with the Hutchinson Lab @socialinfluenza.bsky.social! Please come and find me at poster 005 (block A) if you want to talk about biosafe methods to study HPAIV H5N1 🦠
Reposted by Sarah K Walsh
If you'd like to celebrate the biology of viruses - or the fight against viral diseases - this winter, try out our free and updated #VirusSnowflake designs.
Please share, and if you have any photos of Virus Snowflakes in your area it would be lovely to see them!
cvr-engagement.co.uk/virus-snowfl...
November 17, 2025 at 5:39 PM
Fascinating multi-disciplinary study from @itingtu.bsky.social showing that vampire bats are being exposed to H5 HPAIVs 😄 Really excited to have been a small part of this story and cannot wait to see where it goes next 🦇🦠🦭
My 1st first-author paper is out as a preprint! Excited to share the fascinating story of marine-feeding vampire bats 🌊🦇 We found that marine-diet bats were exposed to #H5#AvianFlu 🦠 from marine wildlife and could potentially spread it to livestock via blood feed🩸
doi.org/10.1101/2025.11.09.686930
November 12, 2025 at 11:41 AM
Reposted by Sarah K Walsh
We talked about this back when the first trial for lenacapavir first said the magic words everyone wants to hear, "halted for efficacy"(*), so a recap: this is not a vaccine or a treatment. It's PrEP aka "pre-exposure prophylaxis": you take the drug so if exposed to the virus, you will not catch it.
If you were alive in the 1980s, this is among the most wonderful & truly incredible things you have ever witnessed in your lifetime.
July 28, 2025 at 4:05 AM
Reposted by Sarah K Walsh
📢 We’re delighted to announce that Professor Emma Thomson has been appointed as the new Director of the CVR.

An internationally recognised expert in emerging infectious diseases, Emma will continue to lead the CVR in its role in national and global pandemic response.

www.gla.ac.uk/research/az/...
Professor Emma Thomson appointed Director of the CVR
We are delighted to announce that Professor Emma Thomson has been appointed as the new Director of the MRC-University of Glasgow Centre for Virus Research (CVR), having taken up the post as Interim Di...
www.gla.ac.uk
June 2, 2025 at 2:25 PM
Important work from the Flu-TrailMap-OneHealth Consortium demonstrating that unpasteurised milk poses a risk of transmitting H5N1 - great to see this out there to help people make informed choices about raw milk consumption (…basically, don’t…)🥛🐄 🐑 🦠
If you don't pasteurise it, how long can H5N1 influenza viruses stay infectious for in milk?
We had a look at this in a new preprint with ‪@cvrinfo.bsky.social‬, @roslininstitute.bsky.social‬, ‪@pirbrightinst.bsky.social‬ & the APHA (1/N)
www.medrxiv.org/content/10.1...
May 29, 2025 at 6:25 PM
Reposted by Sarah K Walsh
Absolutely thrilled to announce the launch of ARTIC2 - a £5.5M 5 year project funded by @wellcometrust.bsky.social to build on the ARTIC approach of low-cost, globally accessible genome sequencing for surveillance of outbreaks, epidemics and endemic diseases: www.birmingham.ac.uk/news/2025/am...
Ambitious project to develop low-cost genome sequencing for pathogens known and unknown - University of Birmingham
Project will build on research that helped diagnostic labs to adopt sequencing capacity for COVID-19 and permit characterisation of future infectious threats
www.birmingham.ac.uk
May 22, 2025 at 10:57 AM
Reposted by Sarah K Walsh
Very excited to be at my first #microbio2025 conference! If emerging infectious diseases, coronaviruses, adaptive immunity or epidemiological modelling interest you come see my talk in the Viruses: Adaptive Immunity session on Wednesday 👨‍⚕️🦠🔬
March 31, 2025 at 4:59 PM
Excited to be at my first @microbiologysociety.org annual conference with the Hutchinson Lab @socialinfluenza.bsky.social! Please come and find me at poster 005 (block A) if you want to talk about biosafe methods to study HPAIV H5N1 🦠
March 31, 2025 at 4:57 PM
Reposted by Sarah K Walsh
1/3 How long do you think it takes for highly pathogenic avian flu H5N1 sequences to be uploaded to GISAID after collection? How long should it be? In this commentary, we find a median delay of 228 days, with half the countries taking more than 6 months. rdcu.be/eeZGU @naturebiotech.bsky.social
Lengthy delays in H5N1 genome submissions to GISAID
Nature Biotechnology - Lengthy delays in H5N1 genome submissions to GISAID
rdcu.be
March 25, 2025 at 5:30 PM
Reposted by Sarah K Walsh
I’ve now been asked about the USDA H5N1 action plan quite a few times, so maybe I should say a few things about it.

There are a few things I like about it, more things I don’t, and some things about it that are completely WTAF.

This is the 5 step plan:
March 20, 2025 at 6:45 PM
Exciting new preprint from Imrie et al looking at how changes in population immunity after the COVID-19 pandemic have influenced the potential emergence of ‘SARS-CoV-X’ (with classically beautiful data vis) @cvrinfo.bsky.social
March 19, 2025 at 1:39 PM